|
Periodicals
| ShowHide Related Items >><< - 10:37 Today
- Denmark to continue vaccine rollout without AstraZeneca COVID-19 vaccine
- 06:20 Today
- AstraZeneca's Tagrisso approved in China in early lung cancer
- 04/12/21
- AstraZeneca's DARE-19 ph.3 trial of Farxiga in COVID-19 failed primary endpoint
- 04/09/21
- AstraZeneca to unveil ARP1 selective inhibitor AZD5305 at AACR
- 09:33 Today
- EMA says 'expediting' evaluation of Johnson & Johnson COVID-19 vaccine
- 04/13/21
- J&J pauses vaccinations in all COVID-19 vaccine clinical trials
- 04/13/21
- White House says J&J pause will not significantly impact vaccination plan
- 04/13/21
- Johnson & Johnson to 'proactively delay' rollout of vaccine in Europe
- 10:59 Today Guggenheim
- Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
- 04/12/21
- Fly Intel: Top five analyst downgrades
- 04/12/21 B. Riley
- B. Riley calls Agenus the next Seagen, reiterates $8 target
- 04/12/21 Argus
- AstraZeneca downgraded to Hold from Buy at Argus
- 10:59 Today Guggenheim
- Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
- 04/13/21 Goldman Sachs
- J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
- 04/13/21 Morgan Stanley
- Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
- 04/13/21 JPMorgan
- Vaccine pause 'incremental negative' for J&J, says JPMorgan
- 04/07/21
- EMA says benefits of AstraZeneca Covid vaccine outweigh side effects
- 02/11/21
- AstraZeneca sees FY21 core EPS $4.75-$5.00
- 02/11/21
- AstraZeneca reports Q4 core EPS $1.07, total revenue $7.41B
- 11/05/20
- AstraZeneca backs view for FY20 core EPS up by a mid- to high-teens percentage
- 01/26/21
- Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45
- 01/26/21
- Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82
- 01/25/21
- Notable companies reporting before tomorrow's open
- 01/25/21
- Notable companies reporting before tomorrow's open
- 04/09/21
- AstraZeneca slashes vaccine deliveries to EU by 49%, FT reports
- 04/09/21
- EU evaluates J&J vaccine for blood clots, widens AstraZeneca probe, Reuters says
- 04/08/21
- Spain recommends AstraZeneca vaccine for over-60s only, FT reports
- 04/08/21
- Official warned that Emergent plant had to be 'monitored closely,' NYT reports
- 15:43 Today
- Moderna discussing COVID vaccine manufacturing with Nexus, Reuters reports
- 11:59 Today
- Italy suspends distribution of J&J COVID-19 vaccines, Reuters reports
- 06:22 Today
- J&J vaccine pause threatens public opinion on COVID-19 vaccines, FT reports
- 06:17 Today
- CDC advisory panel to meet to discuss J&J Covid vaccine, WSJ reports
- 04/09/21
- Fly Intel: Wall Street's top stories for Friday
- 04/09/21
- Fly Intel: Wall Street's top stories at midday
- 04/07/21
- Fly Intel: Wall Street's top stories for Wednesday
- 04/07/21
- FibroGen slides after 'unfavorable disclosure' on safety data for anemia pill
- 04/13/21
- Fly Intel: Wall Street's top stories for Tuesday
- 04/13/21
- Fly Intel: Wall Street's top stories at midday
- 04/13/21
- Johnson & Johnson under pressure as FDA calls for pause on COVID vaccine
- 04/13/21
- Fly Intel: Pre-market Movers
- 04/01/21
- AstraZeneca put volume heavy and directionally bearish
- 03/22/21
- AstraZeneca call volume above normal and directionally bullish
- 03/16/21
- Unusually active option classes on open March 16th
- 02/24/21
- AstraZeneca call volume above normal and directionally bullish
- 04/13/21
- Unusually active option classes on open April 13th
- 04/01/21
- Unusually active option classes on open April 1st
- 03/01/21
- Unusually active option classes on open March 1st
- 01/26/21
- Early notable gainers among liquid option names on January 26th
|
|
On The Fly
|
The major averages had a… ShowHide Related Items >><< - $160.10 /
+10.62 (+7.10%) - 09:24 Today
- Moderna says COVID-19 vaccine seen 90% effective against all cases at six months
- 06:56 Today
- Moderna says 14 different mRNA vaccine candidates entered into trials to date
- 06:54 Today
- Moderna sees Phase 1 study of mRNA flu vaccine candidate to begin in 2021
- 06:53 Today
- Moderna updates on clinical development of HIV vaccine candidates
- 10:41 Today
- Goldman Sachs CEO: 'Not focused' on offering crypto wallet right now
- 10:40 Today
- Goldman Sachs CEO: 'We have a plan at the moment to build a digital bank'
- 09:59 Today
- Goldman Sachs says investment banking backlog ended at record levels in Q1
- 09:43 Today
- Goldman Sachs says focused on scaling consumer digital platform
- 09:29 Today
- JPMorgan CEO calls for 'level playing field' with 'neobanks'
- 09:26 Today
- JPMorgan CEO says buying back stock because 'cup runneth over'
- 09:19 Today
- JPMorgan CEO 'completely open-minded' on acquisitions
- 09:14 Today
- JPMorgan CEO: Plenty of organic growth opportunities we want to invest in
- 10:27 Today
- Wells Fargo sees 'robust' mortgage origination volume
- 10:26 Today
- Wells Fargo sees remainder of pending branch closures this year
- 10:22 Today
- Wells Fargo still sees FY21 NII flat to down 4%
- 10:10 Today
- Wells Fargo 'making good progress' on initiatives to improve business, CEO says
- $327.60 /
-53.37 (-14.01%) - 04/13/21
- Coinbase updates on conversion of Class B shares to Class A shares
- 04/06/21
- Crypto Council for Innovation launches with Square,Coinbase, Fidelity as members
- 03/22/21
- Coinbase ordered to pay $6.5M by CFTC for false, misleading reporting
- 12/17/20
- Coinbase announces confidential submission of draft registration statement
- 04/13/21
- American Airlines sees ending Q1 with $17.3B in total available liquidity
- 04/05/21
- CDC issues updated guidance on travel for fully vaccinated people
- 03/31/21
- American Airlines repays $2.8B in revolving loans related to COVID
- 03/29/21
- American Airlines now sees Q1 system capacity down 40%-45%, up from prior view
- 12:41 Today
- JetBlue names Carol Clements chief digital and technology officer
- 04/13/21
- JetBlue, Qatar Airways expand strategic codeshare agreement
- 04/05/21
- CDC issues updated guidance on travel for fully vaccinated people
- 03/25/21
- JetBlue announces launch of Paisly by JetBlue, a new travel website
- 12:00 Today
- Televisa rises 23.2%
- 10:00 Today
- Televisa rises 29.7%
- 04/13/21
- Televisa, Univision agree to combine content, production assets
GALT Galectin Therapeutics - 04/13/21
- Galectin says Phase 1 belapectin data published in JITC
- 04/06/21
- Galectin Therapeutics launches NAVIGATEnash.com
- 03/31/21
- Galectin expects cash to fund planned operations through March 31, 2022
- 03/08/21
- Galectin Therapeutics announces publication on belapectin galectin-3 inhibitor
- 07:07 Today
- Future FinTech signs equity agreement to acquire cryptocurrency mining farm
- 04/12/21
- Future FinTech enters amended agreement to acquire Nice Talent Asset Management
- 04/01/21
- Future FinTech Group trading resumes
- 04/01/21
- Future FinTech Group trading halted, volatility trading pause
- 04/13/21
- Stitch Fix slips 6.3% to about $46 after CEO transition
- 04/13/21
- Stitch Fix CEO Lake to transition to executive chairperson role
- 03/23/21
- Stitch Fix appoints Sharon Chiarella as Chief Product Officer
- 03/08/21
- Stitch Fix says excited about direct buy active client demand
- $24.52 /
-3.375 (-12.10%) - 07:50 Today
- Bed Bath & Beyond says Q1 sales wont be comparable to 1Q20
- 07:45 Today
- Bed Bath & Beyond drops 7% to $25.97 after mixed Q4 results
- 07:41 Today
- Bed Bath & Beyond reports Q4 digital comp growth of +86%
- 07:15 Today
- Bed Bath & Beyond raises FY21 share repurchase plan to $325M from $300M
- $160.10 /
+10.62 (+7.10%) - 04/13/21 Morgan Stanley
- Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
- 04/13/21 Piper Sandler
- Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
- 04/07/21 Jefferies
- Catalent pact with Moderna removes potential overhang, says Jefferies
- 03/15/21 Piper Sandler
- Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
- 12:56 Today Wells Fargo
- Goldman Sachs price target raised to $385 from $360 at Wells Fargo
- 10:59 Today JMP Securities
- JMP reiterates Outperform rating, $400 target on Goldman after 'blockbuster' Q1
- 04/09/21 JMP Securities
- Goldman Sachs price target raised to $400 from $338 at JMP Securities
- 04/08/21 Citi
- Goldman Sachs price target raised to $390 from $370 at Citi
- 13:53 Today Wells Fargo
- JPMorgan price target raised to $190 from $185 at Wells Fargo
- 04/09/21 Jefferies
- JPMorgan price target raised to $177 from $157 at Jefferies
- 04/07/21 Barclays
- JPMorgan price target raised to $187 from $172 at Barclays
- 04/05/21 Cowen
- Risk to mortgage servicers rises as CFPB proposes foreclosure policy, says Cowen
- 04/09/21 Jefferies
- Wells Fargo price target raised to $45 from $37 at Jefferies
- 04/07/21 Barclays
- Wells Fargo price target raised to $42 from $36 at Barclays
- 04/05/21 Cowen
- Risk to mortgage servicers rises as CFPB proposes foreclosure policy, says Cowen
- 04/01/21 Deutsche Bank
- Wells Fargo price target raised to $45 from $35 at Deutsche Bank
- $327.60 /
-53.37 (-14.01%) - 04/13/21
- Fly Intel: Top five analyst initiations
- 04/13/21 MoffettNathanson
- Coinbase initiated with a Buy at MoffettNathanson
- 04/07/21 JMP Securities
- Coinbase report shows 'substantial business momentum,' says JMP Securities
- 03/03/21
- Fly Intel: Top five analyst initiations
- 04/06/21 Morgan Stanley
- American Airlines initiated with an Underweight at Morgan Stanley
- 03/30/21
- Fly Intel: Top five analyst upgrades
- 03/30/21 Jefferies
- Jefferies upgrades American Airlines to Hold on outperformance potential
- 03/30/21 Citi
- Citi takes 'cautious view' on American Airlines capacity additions
- 09:57 Today
- Fly Intel: Top five analyst upgrades
- 06:02 Today JPMorgan
- JPMorgan double upgrades JetBlue with $25 target on positive risk/reward
- 04:57 Today JPMorgan
- JetBlue upgraded to Overweight from Underweight at JPMorgan
- 04/13/21
- Fly Intel: Top five analyst upgrades
- 03/17/21 BBVA
- Televisa upgraded to Outperform from Market Perform at BBVA
- 12/15/20 Morgan Stanley
- Televisa downgraded to Equal Weight following rally at Morgan Stanley
- 12/15/20 Morgan Stanley
- Televisa downgraded to Equal Weight from Overweight at Morgan Stanley
- 05/12/20 Credit Suisse
- Televisa upgraded to Outperform from Neutral at Credit Suisse
GALT Galectin Therapeutics - 04/05/21 Evercore ISI
- Stitch Fix initiated with an Outperform at Evercore ISI
- 03/09/21
- Fly Intel: Top five analyst downgrades
- 03/09/21 Canaccord
- Stitch Fix price target lowered to $68 from $72 at Canaccord
- 03/09/21 KeyBanc
- Stitch Fix price target lowered to $75 from $95 at KeyBanc
- $24.52 /
-3.375 (-12.10%) - 12:59 Today Wells Fargo
- Bed Bath & Beyond continues to cede market share, says Wells Fargo
- 02/11/21
- Fly Intel: Top five analyst upgrades
- 02/11/21 BofA
- Bed Bath & Beyond upgraded to Buy after pullback at BofA
- 02/11/21 BofA
- Bed Bath & Beyond upgraded to Buy from Neutral at BofA
- $160.10 /
+10.62 (+7.10%) - 02/25/21
- Moderna reports Q4 EPS (69c), consensus (35c)
- 02/24/21
- Notable companies reporting before tomorrow's open
- 02/24/21
- Notable companies reporting before tomorrow's open
- 10/29/20
- Moderna reports Q3 EPS (59c), consensus (43c)
- 07:26 Today
- Goldman Sachs reports Q1 EPS $18.60, consensus $10.22
- 04/13/21
- Fly Intel: What to watch in first round of big bank earnings reports
- 04/13/21
- Notable companies reporting before tomorrow's open
- 01/19/21
- Goldman Sachs reports Q4 EPS $12.08, consensus $7.47
- 06:48 Today
- JPMorgan reports Q1 EPS $4.50, consensus $3.10
- 04/13/21
- Fly Intel: What to watch in first round of big bank earnings reports
- 04/13/21
- Notable companies reporting before tomorrow's open
- 01/15/21
- JPMorgan reports Q4 EPS $3.79, consensus $2.62
- 07:57 Today
- Wells Fargo reports Q1 EPS $1.05, consensus 70c
- 04/13/21
- Fly Intel: What to watch in first round of big bank earnings reports
- 04/13/21
- Notable companies reporting before tomorrow's open
- 01/15/21
- Wells Fargo reports Q4 EPS 64c, consensus 60c
- $327.60 /
-53.37 (-14.01%) - 04/06/21
- Coinbase gives Q2, FY21 expenses guidance
- 04/06/21
- Coinbase reports Q1 estimated total revenue of $1.8B
- 04/13/21
- American Airlines sees Q1 revenue down 62% from last year
- 01/28/21
- American Airlines reports Q4 adjusted EPS ($3.86), consensus ($4.11)
- 01/27/21
- Notable companies reporting before tomorrow's open
- 01/27/21
- Notable companies reporting before tomorrow's open
- 01/28/21
- JetBlue reports Q4 EPS ($1.53) consensus ($1.69)
- 01/27/21
- Notable companies reporting before tomorrow's open
- 01/27/21
- Notable companies reporting before tomorrow's open
- 10/27/20
- JetBlue reports Q3 adj. EPS ($1.75), consensus ($2.00)
GALT Galectin Therapeutics - 03/31/21
- Galectin Therapeutics reports 2020 EPS (41c), one est. (43c)
- 11/09/20
- Galectin Therapeutics reports Q3 EPS (10c), one est. (14c)
- 03/08/21
- Stitch Fix cuts FY21 revenue view to $2.02B-$2.05B from $2.05B-$2.14B
- 03/08/21
- Stitch Fix sees Q3 revenue $505M-$515M, consensus $522.97M
- 03/08/21
- Stitch Fix reports Q2 EPS (20c), consensus (22c)
- 03/08/21
- Notable companies reporting after market close
- $24.52 /
-3.375 (-12.10%) - 07:17 Today
- Bed Bath & Beyond sees Q1 adjusted EBITDA $80M-$90M
- 07:12 Today
- Bed Bath & Beyond reports Q4 adjusted EPS 40c, consensus 31c
- 07:09 Today
- Bed Bath & Beyond sees Q1 core banner sales growth of 65%-70%
- 07:05 Today
- Bed Bath & Beyond sees FY21 revenue $8B-$8.2B, consensus $8.18B
|